Cartesian Therapeutics, Inc.

NASDAQ:RNAC

Biotechnology

Healthcare
$6.30 -4.15%

-$0.41 today

Market cap
$192.17M
Beta
0.78
P/E (TTM)
-1.7
EPS (TTM)
-$5.65
52W Low $5.60High $15.57

Volume 0.17M

Average 0.26M

Balance Sheet

Inspect the capital base behind the business.

Assets

$296.41M

FY 2025 · Annual

-31.9% YoY

Liabilities

$422.65M

FY 2025 · Annual

-4.3% YoY

Equity

-$126.24M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents114.06M106.44M76.91M212.61M125.14M
Short-term Investments14M28.16M000
Net Receivables9.91M9.86M8.85M872K1.12M
Inventory00000
Other Current Assets03.68M4.97M3.14M3.02M
Total Current Assets144.44M148.14M90.73M216.63M129.28M
Property, Plant & Equipment (Net)11.97M14.41M12.18M15.45M17.79M
Goodwill0048.16M48.16M48.16M
Intangible Assets00150.6M150.6M0
Long-term Investments2M2M2M2M1.74M
Tax Assets00000
Other Non-current Assets1.47M1.34M1.38M2.19M99.45M
Total Non-current Assets15.44M17.75M214.32M218.4M167.14M
Total Assets159.88M165.89M305.05M435.02M296.41M
Account Payables224K316K3.15M288K1.29M
Short-term Debt5.96M8.48M004.15M
Tax Payables601K0000
Deferred Revenue53.88M593K2.31M00
Other Current Liabilities0056.19M7.76M5.51M
Total Current Liabilities72.25M25.08M68.21M22.98M14.94M
Long-term Debt19.67M17.79M000
Deferred Tax Liabilities00322.08M16.14M6.95M
Deferred Revenue (Non-current)11.42M03.54M00
Other Non-current Liabilities25.42M19.14M342.62M391.58M392.24M
Total Non-current Liabilities65.11M46.98M677.03M418.85M407.71M
Total Liabilities137.36M72.06M745.23M441.83M422.65M
Common Stock12K15K16K3K3K
Retained Earnings(430.32M)(394.94M)(614.65M)(692.07M)(822.37M)
Accumulated OCI(4.57M)(4.56M)(4.6M)(4.62M)(4.58M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity22.52M93.83M(440.18M)(6.8M)(126.24M)
Total Debt35.28M37.93M10.96M13.98M12.68M
Net Debt(78.78M)(68.51M)(65.96M)(198.63M)(112.46M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$118.6M
Receivables$261.0K
Other Current$3.1M
Total Current Assets$122.0M
PP&E (Net)$17.0M
Goodwill$48.2M
Intangible Assets$93.9M
Long-term Investments$1.7M
Other Non-current$5.6M
Total Non-current Assets$166.4M
Total Assets$288.4M

Analysis

Selected assets total $288.4M for Latest. The largest visible component is Cash & Equivalents at $118.6M, about 41.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 6, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportSep 29, 2026
SC 13GSC 13G filingAug 13, 2026

How much cash does RNAC have?

Cartesian Therapeutics, Inc. (RNAC) reported $125.14M in cash and equivalents in fiscal 2025.

How much debt does RNAC carry?

Cartesian Therapeutics, Inc. (RNAC) reported $12.68M of total debt, with net debt of -$112.46M.